Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HULPURO: Autologous ASC for Stress Urinary Incontinence
NCT01804153Phase 2Unknown
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Sep 2012
- Primary completion
- Oct 2013
- Countries
- 1
01
Overview
Phase 2, open-label trial of adipose-derived expanded stem cells in stress urinary incontinence (SUI), sponsored by Hospital La Paz Institute for Health Research. Primary endpoint: Feasibility and Safety of autologous ASC at 16 weeks. Status: unknown.
02
Drugs
adipose-derived expanded stem cells
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT01804153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01804153.